This topic contains a solution. Click here to go to the answer

Author Question: A patient receiving intravenous heparin (Liquaemin) therapy receives a first dose of warfarin ... (Read 88 times)

Mr3Hunna

  • Hero Member
  • *****
  • Posts: 536
A patient receiving intravenous heparin (Liquaemin) therapy receives a first dose of warfarin (Coumadin). The patient asks the health care provider when the heparin drip will be discontin-ued.
 
  Review the following responses and select the one which is accurate.
  a. Immediately
  b. In 1-2 hours
  c. In 12-24 hours
  d. In 48-72 hours

Question 2

Which of the following conditions would contraindicate the use of warfarin (Coumadin) therapy in a patient?
 
  a. Deep vein thrombosis
  b. Pulmonary embolism
  c. Pregnancy
  d. Hypercoagulability



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

rosiehomeworddo

  • Sr. Member
  • ****
  • Posts: 306
Answer to Question 1

ANS: D
Although the anticoagulant effects of warfarin begin in 8-12 hours, its peak effects do not occur for 48-72 hours. This is because the drug has no effect on existing clotting factors, which take from 6 to 60 hours to decay in the blood stream.

Answer to Question 2

ANS: C
Warfarin is contraindicated for use during pregnancy and lactation.




Mr3Hunna

  • Member
  • Posts: 536
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


mochi09

  • Member
  • Posts: 335
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

For a complete list of videos, visit our video library